A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: Results from a phase II study

1. Antolín, S.
2. Mel, R.
3. Ramos, M.
4. García-Palomo, A.
5. Almanza, C.
6. Paz, L.
7. Calvo, L.
8. Álvarez, E.
9. González, A.
10. García-Mata, J.